Oregon Legislators File Bill to Ensure Psilocybin Equity

Legislators in the state of Oregon have introduced a bicameral initiative that will establish a 15-member group that will focus on psilocybin health equity. The task force will be made up of representatives of the indigenous community, individuals with experience with psychedelic treatment, regulators involved in psilocybin reform implementation and legislators. This comes as the state prepares to implement its first legal psilocybin services program.

The measure, which was introduced by Rep. Wlnsvey Campos and Sen. Lawrence Spence, stipulates that the task force will be responsible for ensuring accessibility and equity in the state’s developing psilocybin services. The group will also be required to look into barriers of access to psychedelic sessions for minority communities and low-income individuals, the training of culturally specific psilocybin services facilitators and barriers that individuals of color face when they want to start psilocybin-related businesses.

This is in addition to studying the regulation of research partnerships that look into the effectiveness of psilocybin therapy and expansion of access to psilocybin services and the development of research-specific licenses for psilocybin.

Additionally, the group will be required to look into a psilocybin equity program that will grow the number of low-income individuals who will hold licenses, run culturally specific practices and offer resources to communities with barriers preventing them from accessing health care. The extensive equity study will help inform legislative and/or regulatory decisions around grants for people who will receive technical and financial assistance to enter the market, decreasing fees for disadvantaged communities and a proposal that centers for psilocybin services dedicate a certain percentage of treatment sessions with psilocybin to low-income clients.

The task force is also mandated to explore the possibility of establishing a psilocybin equity office in the state of Oregon. If the measure is approved, members of the task force will be required to present a report on their findings by Nov. 1, 2022.

In an interview, Oregon Psilocybin Advisory Board member Mason Marks stated that the new initiative was important as Measure 109 didn’t place as much focus on equity, noting that other psychedelic legislations in states such as Washington made equity a priority. The Oregon Psilocybin Advisory Board was established in 2020 under a voter-approved measure.

Marks hopes that future legislations will allow individuals who are unable to go to a psilocybin service center to have access to at-home psilocybin services, as well as more accessible and affordable training opportunities for psychedelic session facilitators.

The Oregon Psilocybin Advisory Board will be issuing recommendations on how the psilocybin program will be implemented in the state by regulators soon. Across the border in Canada, companies such as Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) are already offering ketamine treatments legally, a sign that psychedelics are taking on a new role as medicinal products which are acceptable to the mainstream scientific community.

NOTE TO INVESTORS: The latest news and updates relating to Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) are available in the company’s newsroom at https://ibn.fm/DELCF

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.psychedelicnewswire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.